Gilead Sciences (GILD) Stock: Buy, Sell, or Hold?
GILD - Gilead Sciences Inc
$144.74
-2.76 (-1.87%)
▼
5d:
-4.1%
30d:
-3.26%
90d:
+11.67%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 29, 2026
24d
Get Alerted When GILD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GILD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GILD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$199.53
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$123.89
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GILD is currently trading at $144.74, which is considered oversold relative to its 30-day fair value range of $146.12 to $151.01. The stock's valuation (Forward PE: 14.6) is in line with its historical norms (14.4). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GILD is in a strong uptrend. The price is currently testing key support at $144.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GILD is in a strong uptrend. The price is currently testing key support at $144.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$146.12 -
$151.01
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
Protect Your Profits
Holding GILD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($158.65)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$146.12 -
$151.01
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$144.00
Resistance Level
$154.20
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.64
Wall Street Target
$158.65
(+9.6%)
Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
54.8%
Profit Margin
-10.6%
Valuation Premium vs History
+0.7% premium
PE vs Historical
14.6 vs 14.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$145.75
(+1%)
2-Year Target
$146.77
(+1%)
3-Year Target
$147.80
(+2%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$145.41
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 04, 2026 1:50 AM ET
Data refreshes hourly during market hours. Next update: 2:50 AM
Data refreshes hourly during market hours. Next update: 2:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GILD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Andrew D Dickinson
SELL
3000 shares
2026-04-15
Johanna Mercier
SELL
3000 shares
2026-04-15
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1325 | 48 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$279 | 57 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$389 | 55 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$238 | 48 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$154 | 55 HOLD |
Advanced GILD Option Strategies
Professional options setups generated by AI based on today's GILD price and gamma walls.
